What is Centene's primary Medicare Advantage brand?

Centene's primary Medicare Advantage brand is WellCare, which Centene acquired through its $17.3 billion acquisition of WellCare Health Plans in January 2020. WellCare operates Medicare Advantage plans in multiple states across the United States. Before the WellCare acquisition, Centene had a limited Medicare Advantage presence. The WellCare acquisition transformed Centene into one of the larger Medicare Advantage operators in the United States.

What is SilverScript?

SilverScript is Centene's Medicare Part D prescription drug plan brand, also acquired through the WellCare acquisition in January 2020. SilverScript is one of the largest Medicare Part D prescription drug plan sponsors in the United States, serving millions of Medicare beneficiaries who need standalone prescription drug coverage. SilverScript plans are available nationally to Medicare beneficiaries who want prescription drug coverage without enrolling in a Medicare Advantage plan.

Is Centene Medicare publicly traded?

Centene Medicare is not publicly traded as a separate entity. Its parent company, Centene Corporation, trades on the NYSE under the ticker CNC. Centene reported revenues of approximately $144 billion in fiscal year 2024. Investors seeking exposure to Centene's Medicare operations must purchase shares in Centene Corporation.

Has Centene exited any Medicare Advantage markets?

Yes, Centene announced plans to exit multiple Medicare Advantage markets at the end of 2024 and 2025 due to significant financial losses in its Medicare Advantage business. Medical costs for Medicare Advantage members increased faster than expected, leading Centene to report losses and make the strategic decision to reduce its Medicare Advantage footprint and focus on markets where it can achieve sustainable profitability. This exit disrupted coverage for affected members who needed to find alternative Medicare Advantage plans.

How did Centene become a major Medicare Advantage operator?

Centene became a major Medicare Advantage operator through its $17.3 billion acquisition of WellCare Health Plans, which completed in January 2020. WellCare was one of the largest Medicare Advantage and Medicaid managed care companies in the United States, with millions of Medicare Advantage members across multiple states. The acquisition added WellCare's Medicare Advantage plans, SilverScript prescription drug plans, and Medicaid managed care plans to Centene's portfolio, transforming Centene from a primarily Medicaid-focused company into a major Medicare Advantage operator.

Healthcare & Pharmaceuticals

Who Owns Centene Medicare?

Centene Medicare refers to Centene Corporation's (NYSE: CNC) Medicare Advantage and prescription drug plan offerings. Following Centene's $17.3 billion acquisition of WellCare Health Plans in January 2020, Centene's Medicare Advantage plans are primarily marketed under the WellCare brand nationally, making WellCare one of the largest Medicare Advantage insurers in the United States. Centene also operates SilverScript, one of the largest Medicare Part D prescription drug plan sponsors in the country. Centene reported revenues of approximately $144 billion in fiscal year 2024.

Parent Company

Centene Corporation

Founded

2010

Status

Publicly Traded

Headquarters

St. Louis, Missouri, USA

premiummass marketUnited Statesseniorshealthcare accesspreventive caredigital health solutionsOfficial Website

Who Owns Centene Medicare?

Parent Company: Centene Corporation
Ownership Type: Brand division
Company Type: Publicly Traded
Stock Ticker: NYSE: CNC

Brand	Parent Company	Ownership Type
Centene Medicare	Centene Corporation	Brand division

History of Centene Medicare

Founded: 2010
Founders: Centene Corporation (internal development)

Centene Corporation's origins are in Medicaid managed care, not Medicare. The company was founded in 1984 and built its business primarily around managing Medicaid programs for state governments. For most of its history, Centene had limited involvement in Medicare, focusing instead on expanding its Medicaid managed care operations across multiple states.

Centene began developing Medicare Advantage capabilities in the 2010s as the company sought to diversify beyond Medicaid and serve the full spectrum of government-sponsored health insurance. The company developed Medicare Advantage plans in select markets and began building the infrastructure needed to serve the Medicare population, which has different clinical needs and regulatory requirements than the Medicaid population.

The transformative event in Centene's Medicare history was the announcement in March 2019 of Centene's agreement to acquire WellCare Health Plans for approximately $17.3 billion. WellCare was one of the largest Medicare Advantage and Medicaid managed care companies in the United States, with a strong Medicare Advantage presence across multiple states. The acquisition was strategically motivated by Centene's desire to significantly expand its Medicare Advantage capabilities and membership.

The WellCare acquisition completed in January 2020, following regulatory approval. The acquisition added WellCare's Medicare Advantage plans, Medicare Part D prescription drug plans (operated under the SilverScript brand), and Medicaid managed care plans to Centene's portfolio. WellCare's Medicare Advantage membership, which numbered in the millions, transformed Centene from a primarily Medicaid-focused company into a major Medicare Advantage operator.

Following the acquisition, Centene retained the WellCare brand for Medicare Advantage plans nationally, recognizing that WellCare had strong brand recognition among Medicare beneficiaries. The WellCare brand is now Centene's primary Medicare Advantage brand, operating in multiple states across the country. In Florida specifically, WellCare's Medicare Advantage operations were integrated into the Sunshine Health organizational structure, though the WellCare brand name was retained for Medicare products.

SilverScript, WellCare's Medicare Part D prescription drug plan brand, became one of Centene's most significant Medicare assets following the acquisition. SilverScript is one of the largest Medicare Part D prescription drug plan sponsors in the United States, serving millions of beneficiaries who need prescription drug coverage under Medicare.

Centene has continued to expand its Medicare Advantage membership following the WellCare acquisition, both through organic growth and through the integration of WellCare's operations. The Medicare Advantage market has grown significantly as more Medicare beneficiaries choose Medicare Advantage plans over traditional Medicare, driven by the additional benefits that Medicare Advantage plans typically offer, including dental, vision, and hearing coverage.

However, Centene and other Medicare Advantage insurers have faced significant financial challenges in recent years as medical costs for Medicare Advantage members have increased faster than expected. Centene reported significant losses in its Medicare Advantage business in 2023 and 2024, leading the company to exit certain Medicare Advantage markets and reduce its Medicare Advantage footprint. Centene announced plans to exit multiple Medicare Advantage markets at the end of 2024 and 2025, focusing its Medicare Advantage operations on markets where it can achieve sustainable profitability.

About Centene Corporation

Centene Corporation operates through two main business segments: Managed Care and Specialty Services. The Managed Care segment provides health insurance coverage through Medicaid, Medicare Advantage, and marketplace health plans. The company serves millions of members across multiple states with locally branded health plans.

The Specialty Services segment includes pharmacy benefits management, behavioral health services, care management, and other healthcare services. Centene's specialty services complement its managed care offerings and provide integrated healthcare solutions for complex populations.

Centene's business model focuses on government-sponsored healthcare programs, making the company highly dependent on public policy and government funding. The company operates health plans under various local brand names, maintaining a community-focused approach while leveraging national scale and expertise.

Centene employs approximately 74,000 people nationwide and generates annual revenues exceeding $140 billion. The company serves as a critical intermediary between government healthcare programs and healthcare providers, ensuring access to care for vulnerable populations.

Founded: 1984
Headquarters: St. Louis, Missouri, USA
Company Type: Publicly Traded
Stock: NYSE: CNC
Revenue: approximately $166.0 billion (FY2024)
Employees: Approximately 75,000

Visit Centene Corporation website

View full company profile for Centene Corporation

Where Is Centene Medicare Made / Based?

Headquarters: St. Louis, Missouri, USA
Manufacturing / Operations: United States

Centene Medicare Sustainability & Ethics

Centene Medicare operates under Centene Corporation's comprehensive sustainability framework, which includes healthcare access initiatives, environmental stewardship, and ethical business practices. As a Medicare Advantage provider, Centene's sustainability considerations encompass healthcare access equity, preventive care programs, environmental impact of healthcare operations, and ethical management of government-sponsored health programs.

Centene has implemented significant programs to improve healthcare access for underserved populations, particularly through its Medicaid and Medicare Advantage offerings. The company has committed to expanding access to care through telehealth services, community health partnerships, and culturally competent care programs. Centene Medicare operations participate in these sustainability initiatives, implementing digital health solutions and community outreach programs to improve healthcare equity.

Environmental sustainability is another key focus area. Centene has implemented programs to reduce the environmental impact of healthcare operations, including energy-efficient facilities, waste reduction programs, and sustainable procurement practices. The company has committed to reducing greenhouse gas emissions and implementing environmentally responsible practices across its administrative and clinical operations.

The company has implemented preventive care and population health management programs that focus on keeping Medicare beneficiaries healthy and reducing hospitalizations. Centene Medicare operations participate in these initiatives, implementing care coordination programs, chronic disease management, and wellness programs that improve health outcomes while reducing healthcare costs.

Centene faces ongoing scrutiny regarding Medicare Advantage plan pricing, benefit adequacy, and claims processing practices. As a major government-sponsored health insurer, Centene has been subject to regulatory oversight and consumer advocacy group attention regarding the value and quality of Medicare Advantage plans offered to beneficiaries.

Awards & Recognition

Centene Medicare has received recognition primarily through its WellCare and SilverScript brands for healthcare quality, innovation in Medicare services, and contributions to senior healthcare access, though awards focus more on healthcare excellence than brand marketing recognition.

Medicare Advantage Quality Recognition: WellCare Medicare Advantage plans have received recognition from healthcare quality organizations for achieving high star ratings from the Centers for Medicare and Medicaid Services (CMS), which measure plan quality and performance.
Healthcare Innovation Awards: Centene's digital health solutions and telehealth programs for Medicare beneficiaries have been recognized by healthcare technology organizations for improving access to care for senior populations.
Preventive Care Excellence: Centene's preventive care programs and chronic disease management initiatives for Medicare Advantage members have received recognition from healthcare quality organizations for improving health outcomes.
Senior Healthcare Access Recognition: Centene's contributions to expanding Medicare Advantage access in underserved communities have been acknowledged by senior advocacy organizations and healthcare access groups.
Digital Health Innovation: The company's implementation of digital health platforms and remote monitoring technologies for Medicare beneficiaries has received recognition from healthcare technology publications.
Corporate Social Responsibility Recognition: Centene's community health initiatives and programs addressing social determinants of health for Medicare populations have been acknowledged by healthcare advocacy organizations.

Centene Medicare Recalls & Controversies

Centene Medicare has faced several significant controversies and operational challenges throughout its history, primarily related to financial losses, market exits, and concerns about Medicare Advantage plan quality and pricing.

2023-2024 Medicare Advantage Financial Losses: Centene reported significant losses in its Medicare Advantage business in 2023 and 2024 as medical costs increased faster than expected. These losses led to major strategic decisions and raised concerns about the company's ability to effectively manage Medicare Advantage populations.

Market Exit Controversy (2024-2025): Centene announced plans to exit multiple Medicare Advantage markets at the end of 2024 and 2025, disrupting coverage for thousands of affected members. This exit created significant controversy and criticism from beneficiary advocacy groups and regulators concerned about coverage continuity.

Medicare Advantage Plan Quality Concerns: Centene has faced scrutiny regarding the quality and adequacy of benefits offered by some WellCare Medicare Advantage plans, particularly regarding network adequacy and prior authorization processes that can affect beneficiary access to care.

Pricing and Premium Increases: Some WellCare Medicare Advantage plans have faced criticism for premium increases and cost-sharing changes that affect beneficiary affordability, particularly in markets where medical costs have risen significantly.

Claims Processing Issues: Like many Medicare Advantage insurers, Centene has faced complaints and regulatory scrutiny regarding claims processing delays, denials, and appeals processes that can affect beneficiary access to covered services.

Regulatory Compliance Challenges: Centene has faced regulatory oversight and compliance challenges related to Medicare Advantage program requirements, including CMS quality ratings and marketing regulations that govern how Medicare Advantage plans can be marketed to beneficiaries.

WellCare Integration Issues: Following the 2020 acquisition, Centene faced challenges integrating WellCare operations with existing Centene systems and processes, which affected service quality and operational efficiency in some markets during the transition period.

Brands Owned by Centene Corporation

Sunshine Health - Centene Corporation's Florida-based health insurance brand providing Medicaid ma...
WellCare - Centene Corporation's national Medicare Advantage and prescription drug plan bra...

View all brands owned by Centene Corporation

Centene Medicare Ownership: Pros & Cons

Advantages

+The WellCare brand, acquired through Centene's $17.3 billion acquisition of WellCare Health Plans in January 2020, provides Centene with strong Medicare Advantage brand recognition and an established membership base across multiple states
+SilverScript's position as one of the largest Medicare Part D prescription drug plan sponsors in the United States provides Centene with a significant and relatively stable revenue stream from Medicare prescription drug coverage
+Centene's expertise in managing government-sponsored health insurance programs, developed through decades of Medicaid managed care experience, provides transferable capabilities for managing Medicare Advantage populations
+The Medicare Advantage market has grown significantly as more Medicare beneficiaries choose Medicare Advantage over traditional Medicare, driven by additional benefits including dental, vision, and hearing coverage that Medicare Advantage plans typically offer
+Centene's scale as one of the largest managed care companies in the United States provides purchasing power and administrative efficiencies that support competitive Medicare Advantage plan pricing

Considerations

-Centene reported significant losses in its Medicare Advantage business in 2023 and 2024 as medical costs increased faster than expected, leading the company to exit multiple Medicare Advantage markets and reduce its Medicare Advantage footprint
-The Medicare Advantage market has become increasingly competitive, with UnitedHealth Group, Humana, and CVS Health's Aetna dominating the market and having significantly more experience and scale in Medicare Advantage than Centene
-Medicare Advantage reimbursement rates are set by the Centers for Medicare and Medicaid Services (CMS) and are subject to annual changes that can significantly affect the profitability of Medicare Advantage plans
-The complexity of managing Medicare populations, which have significantly higher medical costs and more complex clinical needs than Medicaid populations, creates operational challenges for a company that built its expertise primarily in Medicaid managed care
-Centene's exit from multiple Medicare Advantage markets at the end of 2024 and 2025 disrupted coverage for affected members and created reputational risks for the WellCare brand in those markets

Frequently Asked Questions About Centene Medicare

Sources & Further Reading

Centene Corporation Official Website -
Centene Investor Relations -
SEC EDGAR: Centene (CNC) filings -
NYSE: CNC Centene stock -
Wikidata: Centene Corporation entity -
CMS: Medicare Advantage enrollment data -
WellCare Medicare Plans -
SilverScript Prescription Drug Plans -
Medicare Rights Center -
Kaiser Family Foundation: Medicare Advantage Research -
Senior Healthcare Quality Reports -- Healthcare quality assessment publications

Where to Buy

Disclosure: We may earn commission from purchases

Centene Medicare on Amazon

Competitors to Centene Medicare

No direct competitors found in the same category. This could be because Centene Medicareoperates in a unique market segment or we're still building our competitor database.

Centene Corporation Stock Information

Jobs at Centene Corporation

Latest News About Centene Medicare

People Also Searched

Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Branddermatology

Accutane

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Brand in Healthcare & Pharmaceuticals

acne-treatmentprescription

Brandpharmaceutical

Activase

Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.

Brand in Healthcare & Pharmaceuticals

thrombolyticstroke-treatment

Brandcontact-lenses

Acuvue

Acuvue is the world's leading contact lens brand, owned by Johnson & Johnson Vision Care, a division of Johnson & Johnson. The brand covers daily, weekly, and monthly disposable soft contact lenses sold in more than 100 countries.